The genetics of Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Area of Science:

• Genetics and Molecular Biology
• Pediatric Nephrology
• Medical Genetics

Background:

• Autosomal recessive polycystic kidney disease (ARPKD) is an inherited disorder characterized by enlarged, cystic kidneys and liver fibrosis.
• The clinical presentation of ARPKD exhibits significant variability, with a 30% mortality rate in infancy and a generally better prognosis for survivors beyond the first year.
• The underlying genetic basis involves mutations in specific genes, but the reasons for the wide spectrum of disease severity are not fully understood.

Purpose of the Study:

• To review the genetic factors contributing to Autosomal recessive polycystic kidney disease (ARPKD).
• To explore potential genetic modifiers that influence disease variability and prognosis.
• To discuss phenocopies that may complicate the diagnostic process for ARPKD.

Main Methods:

• Literature review of genetic studies related to ARPKD.
• Analysis of known causative genes (PKHD1, DZIP1L) and their mutation spectrum.
• Exploration of research on genetic modifiers and phenocoptic conditions.

Main Results:

• Mutations in the PKHD1 gene are the primary cause of most ARPKD cases.
• Mutations in the DZIP1L gene are associated with a moderate form of ARPKD.
• The variability in ARPKD severity is likely influenced by factors beyond mutations in PKHD1 and DZIP1L, including other genetic modifiers.

Conclusions:

• The genetics of ARPKD are complex, involving key genes like PKHD1 and DZIP1L.
• Understanding genetic modifiers is crucial for explaining the diverse clinical outcomes observed in ARPKD patients.
• Further research into genetic modifiers and phenocopies will improve ARPKD diagnosis and management.